20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | 2024-10-25 17:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | 2024-06-20 00:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | 2024-01-02 06:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | 2023-12-15 00:00:00 |
20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | 2023-10-27 16:15:39 |
6-K | Report of foreign private issuer [Rules 13a-16 OR 15d-16] | 2023-06-15 00:00:00 |
6-K | Report of foreign private issuer [Rules 13a-16 OR 15d-16] | 2023-06-05 00:00:00 |
6-K | Report of foreign private issuer [Rules 13a-16 OR 15d-16] | 2023-03-17 00:00:00 |
6-K | Report of foreign private issuer [Rules 13a-16 OR 15d-16] | 2023-02-28 00:00:00 |
6-K | Report of foreign private issuer [Rules 13a-16 or 15d-16] | 2022-12-22 00:00:00 |
20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | 2022-10-31 00:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 or 15d-16] | 2022-09-12 00:00:00 |
SC 13D | Acquisition Statement | 2022-07-25 00:00:00 |
6-K | Regencell Bioscience Holdings Limited Announces First Half 2022 Management Financial Results [Rules 13a-16 or 15d-16] | 2022-06-02 00:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 or 15d-16] | 2022-05-18 00:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 or 15d-16] | 2022-05-16 00:00:00 |
SC 13D/A | General statement of acquisition of beneficial ownership - amendment | 2022-05-16 00:00:00 |
SC 13D | Acquisition Statement | 2022-03-31 00:00:00 |
6-K | Report of foreign issuer [Rules 13a-16 or 15d-16] | 2022-02-16 00:00:00 |
SC 13D/A | General statement of acquisition of beneficial ownership - amendment | 2021-12-30 00:00:00 |
SC 13G | Statement of acquisition of beneficial ownership by individuals | 2021-12-15 00:00:00 |
6-K | Report of foreign issuer [rules 13a-16 and 15d-16] | 2021-12-13 00:00:00 |
SC 13D/A | Acquisition Statement [Amended] | 2021-11-22 00:00:00
|
6-K | Foreign Issuer Report | 2021-11-17 00:00:00
|
20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
| 2021-10-29 00:00:00 |
6-K | Foreign Issuer Report | 2021-09-07 00:00:00 |
6-K | Foreign Issuer Report | 2021-09-01 00:00:00 |
6-K | Foreign Issuer Report | 2021-08-20 16:05:08 |
SC 13D | Acquisition Statement | 2021-07-27 16:33:02 |
424B4 | Prospectus [Rule 424(b)(4)] | 2021-07-20 00:00:00
|
6-K | Foreign Issuer Report | 2021-07-20 00:00:00
|
EFFECT | Notice of Effectiveness | 2021-07-16 00:15:16
|
8-A12B | Securities Registration | 2021-07-15 00:00:00
|
CERT | Certification | 2021-07-15 00:00:00
|
CORRESP | S.E.C. Correspondence Letter | 2021-07-13 15:30:34
|
CORRESP | S.E.C. Correspondence Letter | 2021-07-13 15:30:34
|
FWP | Free Writing Prospectus | 2021-07-08 00:00:00
|
FWP | Free Writing Prospectus | 2021-06-30 00:00:00
|
CORRESP | S.E.C. Correspondence Letter | 2021-06-22 17:53:37
|
F-1/A | Foreign Private Issuer Registration [Amended] | 2021-06-22 17:52:20
|
UPLOAD | Securities Filing Public Response | 2021-06-21 09:30:04
|
CORRESP | S.E.C. Correspondence Letter | 2021-06-11 17:19:02
|
F-1/A | Foreign Private Issuer Registration [Amended] | 2021-06-11 00:00:00
|
UPLOAD | Securities Filing Public Response | 2021-05-03 16:30:12
|
CORRESP | S.E.C. Correspondence Letter | 2021-04-26 13:16:18
|
F-1/A | Foreign Private Issuer Registration [Amended] | 2021-04-26 00:00:00
|
UPLOAD | Securities Filing Public Response | 2021-04-05 15:30:06
|
CORRESP | S.E.C. Correspondence Letter | 2021-03-22 15:32:21
|
F-1 | Foreign Private Issuer Registration | 2021-03-22 00:00:00
|
UPLOAD | Securities Filing Public Response | 2021-02-18 12:30:07
|
DRSLTR | Registration Statement [Draft] | 2021-02-03 19:25:57
|
DRS/A | Registration Statement [Draft] [Amended] | 2021-02-03 19:23:29
|
UPLOAD | Securities Filing Public Response | 2020-12-11 09:11:46
|
DRS | Registration Statement [Draft] | 2020-11-13 17:24:21
|